Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal VLK Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | VLK antibody was raised against a 15 amino acid synthetic peptide from near the center of human VLK. The immunogen is located within amino acids 320 - 370 of VLK. |
Rabbit Polyclonal IRAK-M Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | IRAK-M antibody was raised against a peptide corresponding to 16 amino acids near the carboxy terminus of human IRAK-M. The immunogen is located within the last 50 amino acids of IRAK-M. |
Rabbit polyclonal DAPK1 Antibody (C-term)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This DAPK1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1360-1389 amino acids from the C-terminal region of human DAPK1. |
Rabbit Polyclonal ZIPK Antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | ZIP kinase antibody was raised against a peptide corresponding to amino acids near the center of human ZIP kinase. The immunogen is located within amino acids 270 - 320 of ZIPK. |
Rabbit Polyclonal antibody to CaMKII delta (calcium/calmodulin-dependent protein kinase II delta)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 249 and 445 of CaMK2D (Uniprot ID#Q13557) |
Rabbit Polyclonal antibody to CaMK1D (calcium/calmodulin-dependent protein kinase ID)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 385 of CaMK1D (Uniprot ID#Q8IU85) |
Rabbit polyclonal PKC zeta (Thr410) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKC? around the phosphorylation site of threonine 410 (T-S-TP-F-C). |
| Modifications | Phospho-specific |
Rabbit polyclonal ETK / BMX(Ab-566) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human ETK around the phosphorylation site of tyrosine 566 (D-Q-YP-V-S). |
Rabbit polyclonal TGFBR2 Antibody (N-term)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This TGFBR2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 13-40 amino acids from the N-terminal region of human TGFBR2. |
Rabbit polyclonal CSFR (Ab-809) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CSFR around the phosphorylation site of tyrosine 809 (S-N-YP-I-V). |
Rabbit polyclonal TNK2 / ACK1 (Tyr284) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human ACK1 around the phosphorylation site of tyrosine 284 (D-H-YP-V-M). |
| Modifications | Phospho-specific |
Rabbit polyclonal p38 MAPK (Ab-322) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human p38 MAPK around the phosphorylation site of tyreonine 322 (D-P-Y-D-Q). |
Rabbit polyclonal antibody to PRKACA (protein kinase, cAMP-dependent, catalytic, alpha)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 351 of PKA C alpha (Uniprot ID#P17612) |
Rabbit Polyclonal antibody to FAST (Fas-activated serine/threonine kinase)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 346 and 549 of FAST (Uniprot ID#Q14296) |
Rabbit polyclonal COT (Ab-290) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human COT around the phosphorylation site of threonine 290 (R-G-TP-E-I). |
Rabbit polyclonal Ret (Ab-905) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Ret around the phosphorylation site of tyrosine 905 (D-S-YP-V-K). |
Rabbit polyclonal antibody to serine/threonine kinase 40 (serine/threonine kinase 40)
| Applications | IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 156 and 372 of serine/threonine kinase 40 (Uniprot ID#Q8N2I9) |
Rabbit Polyclonal antibody to STK25 (serine/threonine kinase 25 (STE20 homolog, yeast))
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 231 of STK25 (Uniprot ID#O00506) |
Rabbit Polyclonal antibody to EEF2K (eukaryotic elongation factor-2 kinase)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 268 of EEF2K (Uniprot ID#O00418) |
Rabbit Polyclonal antibody to AMPK alpha 2 (protein kinase, AMP-activated, alpha 2 catalytic subunit)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 29 and 510 of AMPK alpha 2 (Uniprot ID#P54646) |
Rabbit polyclonal PDGFR beta (Ab-1021) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PDGFR β around the phosphorylation site of tyrosine 1021 (N-D-YP-I-I). |
Rabbit polyclonal Raf1 (Ab-621) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human RAF1 around the phosphorylation site of serine 621 (S-A-S-E-P). |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Mouse
Applications
- IF
Isotypes
- IgG
Families
- Protein Kinase
Filter by
Target Symbol
- AKT1 (7)
- PRKACA (3)
- RPS6KA1 (3)
- BMX (2)
- BRSK1 (2)
- CAMK1D (2)
- CDK2 (2)
- CHEK2 (2)
- CSNK1A1 (2)
- DYRK1A (2)
- EGFR (2)
- EPHA2 (2)
- ERN1 (2)
- GRK6 (2)
- IRAK3 (2)
- LCK (2)
- MAP2K2 (2)
- MAPK14 (2)
- MET (2)
- MTOR (2)
- PAK2 (2)
- PRKCQ (2)
- PRKD1 (2)
- PTK2B (2)
- RPS6KB1 (2)
- AAK1 (1)
- ABL1 (1)
- ACVR1B (1)
- ACVR1C (1)
- ACVRL1 (1)
- ADCK1 (1)
- AKT2 (1)
- ARAF (1)
- BCKDK (1)
- BCR (1)
- BMPR1B (1)
- BRAF (1)
- BRSK2 (1)
- BTK (1)
- BUB1 (1)
- CAMK2D (1)
- CAMKV (1)
- CASK (1)
- CDK1 (1)
- CDK6 (1)
- CDK9 (1)
- CLK1 (1)
- COQ8B (1)
- CSF1R (1)
- CSK (1)
- CSNK1A1L (1)
- DAPK1 (1)
- DAPK3 (1)
- DCLK1 (1)
- DCLK2 (1)
- DCLK3 (1)
- EEF2K (1)
- EIF2AK2 (1)
- EPHA6 (1)
- EPHB1 (1)
- EPHB6 (1)
- ERBB3 (1)
- ERBB4 (1)
- FASTK (1)
- FGFR3 (1)
- FLT1 (1)
- FLT3 (1)
- FLT4 (1)
- FRK (1)
- GSK3A (1)
- GSK3B (1)
- HIPK4 (1)
- HSPB8 (1)
- ICK (1)
- IGF1R (1)
- IKBKB (1)
- IRAK1 (1)
- IRAK2 (1)
- JAK1 (1)
- JAK2 (1)
- KSR2 (1)
- LATS2 (1)
- LIMK2 (1)
- MAP3K1 (1)
- MAP3K20 (1)
- MAP3K5 (1)
- MAP3K7 (1)
- MAP3K8 (1)
- MAP4K4 (1)
- MAP4K5 (1)
- MAPK4 (1)
- MAPK6 (1)
- MAPK8 (1)
- MAPKAPK5 (1)
- MARK4 (1)
- MAST4 (1)
- NEK7 (1)
- NLK (1)
- NTRK2 (1)
- PAK1 (1)
Antibody Hosts
Clonalities
Conjugates
Modifications
Pathways
- MAPK signaling pathway (43)
- Pathways in cancer (41)
- Neurotrophin signaling pathway (32)
- ErbB signaling pathway (29)
- Focal adhesion (28)
- Chemokine signaling pathway (27)
- Insulin signaling pathway (26)
- Progesterone-mediated oocyte maturation (25)
- Prostate cancer (25)
- T cell receptor signaling pathway (25)
- Colorectal cancer (23)
- Glioma (22)
- Melanoma (21)
- mTOR signaling pathway (21)
- Chronic myeloid leukemia (20)
- Pancreatic cancer (20)
- Acute myeloid leukemia (19)
- Endocytosis (19)
- Toll-like receptor signaling pathway (19)
- Non-small cell lung cancer (18)
- Renal cell carcinoma (18)
- Adipocytokine signaling pathway (17)
- Apoptosis (17)
- Endometrial cancer (17)
- GnRH signaling pathway (17)
- Regulation of actin cytoskeleton (17)
- Fc epsilon RI signaling pathway (16)
- Axon guidance (15)
- Tight junction (15)
- B cell receptor signaling pathway (14)
- Cytokine-cytokine receptor interaction (14)
- Fc gamma R-mediated phagocytosis (14)
- VEGF signaling pathway (14)
- Oocyte meiosis (13)
- Vascular smooth muscle contraction (13)
- Wnt signaling pathway (13)
- Calcium signaling pathway (12)
- Gap junction (12)
- Long-term potentiation (12)
- Small cell lung cancer (12)
- Adherens junction (11)
- Epithelial cell signaling in Helicobacter pylori infection (11)
- Jak-STAT signaling pathway (11)
- Bladder cancer (10)
- Cell cycle (10)
- Natural killer cell mediated cytotoxicity (10)
- TGF-beta signaling pathway (9)
- Melanogenesis (8)
- RIG-I-like receptor signaling pathway (8)
- Hedgehog signaling pathway (7)
- Leukocyte transendothelial migration (6)
- Long-term depression (6)
- NOD-like receptor signaling pathway (6)
- Type II diabetes mellitus (6)
- p53 signaling pathway (6)
- Prion diseases (5)
- Olfactory transduction (4)
- Regulation of autophagy (4)
- Thyroid cancer (4)
- Alzheimer's disease (3)
- Amyotrophic lateral sclerosis (ALS) (3)
- Cytosolic DNA-sensing pathway (3)
- Dilated cardiomyopathy (3)
- Pathogenic Escherichia coli infection (3)
- Primary immunodeficiency (3)
- Taste transduction (3)
- Vibrio cholerae infection (3)
- Dorso-ventral axis formation (2)
- Hematopoietic cell lineage (2)
- Basal cell carcinoma (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Non-homologous end-joining (1)
- PPAR signaling pathway (1)
- Parkinson's disease (1)
- Ubiquitin mediated proteolysis (1)
- Viral myocarditis (1)